Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital nephrotic syndrome, Finnish type is characterized by protein loss beginning during fetal life.
Features include always present findings: Nephrotic syndrome, Hypoproteinemia, Hypoalbuminemia, and Anasarca and others; and common findings: Stage 5 chronic kidney disease. 22 total HPO annotations.
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 2:14 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 7 | Stage 5 chronic kidney disease, Nephrotic syndrome, Reduced kidney function (renal insufficiency) |
Digestive system | 2 | Gastroesophageal reflux, Abdominal distention |
Pregnancy and birth | 2 | Congenital nephrotic syndrome, Neonatal respiratory distress |
Metabolism | 1 | High blood fat levels (hyperlipidemia) |
Blood and immune system | 1 | Recurrent infections |
Muscles | 1 | Renal tubular atrophy |
Hormones | 1 | Hypothyroidism |
Growth and development | 1 | Growth delay |
Lungs and breathing | 1 | Neonatal respiratory distress |
NPHS1 encodes NPHS1 adhesion molecule, nephrin (1,241 aa). Seems to play a role in the development or function of the kidney glomerular filtration barrier. Regulates glomerular vascular permeability. Highest expression in Kidney Cortex (36.8 TPM) and Pancreas (15.9 TPM).
Congenital nephrotic syndrome, Finnish type is caused by mutations in the NPHS1 gene on chromosome 19.
The NPHS1 protein participates in Nephrin family interactions pathway.
NPHS1 is classified as a druggable target with score 19.0.
Genetic testing for NPHS1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital nephrotic syndrome, Finnish type has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 1 common feature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for congenital nephrotic syndrome, Finnish type.
26 publications have been identified in PubMed for congenital nephrotic syndrome, Finnish type. Research spans Case Report / Case Series (27%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 27% |
Laboratory research | 7 | 27% |
Disease patterns and progression | 5 | 19% |
Other research | 2 | 8% |
Testing and diagnosis research | 2 | 8% |
Clinical study results | 2 | 8% |
Research summaries | 1 | 4% |
Chowdhury U (2026). [PMID: 41651545](https://pubmed.ncbi.nlm.nih.gov/41651545/). *BMJ Case Rep*. [Case Report / Case Series]
Annicchiarico Petruzzelli L (2026). [PMID: 41495530](https://pubmed.ncbi.nlm.nih.gov/41495530/). *CEN Case Rep*. [Case Report / Case Series]
Bhimma R (2026). [PMID: 41100440](https://pubmed.ncbi.nlm.nih.gov/41100440/). *Nephron*. [Diagnostic / Biomarker]
Zafar F (2025). [PMID: 40761226](https://pubmed.ncbi.nlm.nih.gov/40761226/). *AME Case Rep*. [Case Report / Case Series]
Schneider R (2025). [PMID: 39003671](https://pubmed.ncbi.nlm.nih.gov/39003671/). *J Nephrol*. [Basic Science / Preclinical]
Tsuhako H (2025). [PMID: 41241432](https://pubmed.ncbi.nlm.nih.gov/41241432/). *J Pharmacol Sci*. [Diagnostic / Biomarker]
Zhang W (2025). [PMID: 41163923](https://pubmed.ncbi.nlm.nih.gov/41163923/). *Front Pediatr*. [Case Report / Case Series]
Simons M (2025). [PMID: 40543925](https://pubmed.ncbi.nlm.nih.gov/40543925/). *Kidney Int*. [Basic Science / Preclinical]
Wolff JM (2025). [PMID: 40316169](https://pubmed.ncbi.nlm.nih.gov/40316169/). *Kidney Int*. [Basic Science / Preclinical]
Oldenmark BOV (2025). [PMID: 40669863](https://pubmed.ncbi.nlm.nih.gov/40669863/). *Neuropediatrics*. [Case Report / Case Series]